BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 15700953)

  • 21. A genetic model to investigate drug-target interactions at the ribosomal decoding site.
    Hobbie SN; Bruell C; Kalapala S; Akshay S; Schmidt S; Pfister P; Böttger EC
    Biochimie; 2006 Aug; 88(8):1033-43. PubMed ID: 16690195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aminoglycoside Resistance: Updates with a Focus on Acquired 16S Ribosomal RNA Methyltransferases.
    Wachino JI; Doi Y; Arakawa Y
    Infect Dis Clin North Am; 2020 Dec; 34(4):887-902. PubMed ID: 33011054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The emergence and implications of metallo-beta-lactamases in Gram-negative bacteria.
    Walsh TR
    Clin Microbiol Infect; 2005 Nov; 11 Suppl 6():2-9. PubMed ID: 16209700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of aminoglycoside antibiotics with rRNA.
    Trylska J; Kulik M
    Biochem Soc Trans; 2016 Aug; 44(4):987-93. PubMed ID: 27528743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlations between aminoglycoside consumption and aminoglycoside resistance in Gram-negative bacteria at a tertiary-care hospital in South Korea from 2001 to 2011.
    Ku NS; Choi JY; Yong D; Kim JM; Lee K
    Int J Antimicrob Agents; 2013 Apr; 41(4):394-5. PubMed ID: 23305659
    [No Abstract]   [Full Text] [Related]  

  • 26. Exogenously acquired 16S rRNA methyltransferases found in aminoglycoside-resistant pathogenic Gram-negative bacteria: an update.
    Wachino J; Arakawa Y
    Drug Resist Updat; 2012 Jun; 15(3):133-48. PubMed ID: 22673098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global spread of multiple aminoglycoside resistance genes.
    Yamane K; Wachino J; Doi Y; Kurokawa H; Arakawa Y
    Emerg Infect Dis; 2005 Jun; 11(6):951-3. PubMed ID: 15963295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RmtC introduces G1405 methylation in 16S rRNA and confers high-level aminoglycoside resistance on Gram-positive microorganisms.
    Wachino J; Shibayama K; Kimura K; Yamane K; Suzuki S; Arakawa Y
    FEMS Microbiol Lett; 2010 Oct; 311(1):56-60. PubMed ID: 20722735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An aminoglycoside microarray platform for directly monitoring and studying antibiotic resistance.
    Disney MD; Barrett OJ
    Biochemistry; 2007 Oct; 46(40):11223-30. PubMed ID: 17867707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The synthesis and 16S A-site rRNA recognition of carbohydrate-free aminoglycosides.
    Wang X; Migawa MT; Sannes-Lowery KA; Swayze EE
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4919-22. PubMed ID: 16168642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
    J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural basis for aminoglycoside inhibition of bacterial ribosome recycling.
    Borovinskaya MA; Pai RD; Zhang W; Schuwirth BS; Holton JM; Hirokawa G; Kaji H; Kaji A; Cate JH
    Nat Struct Mol Biol; 2007 Aug; 14(8):727-32. PubMed ID: 17660832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance to polymyxins: Mechanisms, frequency and treatment options.
    Falagas ME; Rafailidis PI; Matthaiou DK
    Drug Resist Updat; 2010; 13(4-5):132-8. PubMed ID: 20843473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A molecular dynamics simulation study of an aminoglycoside/A-site RNA complex: conformational and hydration patterns.
    Vaiana AC; Westhof E; Auffinger P
    Biochimie; 2006 Aug; 88(8):1061-73. PubMed ID: 16824662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a miniaturised microarray-based assay for the rapid identification of antimicrobial resistance genes in Gram-negative bacteria.
    Batchelor M; Hopkins KL; Liebana E; Slickers P; Ehricht R; Mafura M; Aarestrup F; Mevius D; Clifton-Hadley FA; Woodward MJ; Davies RH; Threlfall EJ; Anjum MF
    Int J Antimicrob Agents; 2008 May; 31(5):440-51. PubMed ID: 18243668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combating evolution with intelligent design: the neoglycoside ACHN-490.
    Armstrong ES; Miller GH
    Curr Opin Microbiol; 2010 Oct; 13(5):565-73. PubMed ID: 20932796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular determinants of affinity for aminoglycoside binding to the aminoglycoside nucleotidyltransferase(2'')-Ia.
    Wright E; Serpersu EH
    Biochemistry; 2006 Aug; 45(34):10243-50. PubMed ID: 16922499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aminoglycoside-induced reduction in nucleotide mobility at the ribosomal RNA A-site as a potentially key determinant of antibacterial activity.
    Kaul M; Barbieri CM; Pilch DS
    J Am Chem Soc; 2006 Feb; 128(4):1261-71. PubMed ID: 16433544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNA as a drug target: the case of aminoglycosides.
    Vicens Q; Westhof E
    Chembiochem; 2003 Oct; 4(10):1018-23. PubMed ID: 14523919
    [No Abstract]   [Full Text] [Related]  

  • 40. [Virulence blocking antibiotics. Anti-bacterial agents with completely new action mechanisms].
    Sundin C; Elofsson M; Wolf-Watz H; Rosell S
    Lakartidningen; 2009 Sep 30-Oct 6; 106(40):2543-5. PubMed ID: 19908625
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.